Evaluation Ofe the Anxiolytic Effect of EMONO in Children During Dental Care (MOPEA)

NCT03998774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2021-09-13

No results posted yet for this study

Summary

The EquiMolar Oxygen and Nitrous Oxyde mix (EMONO) is listed by the ANSM (National Agency for the Safety of Medicines and Health Products) as drugs with enhanced surveillance. EMONO is a gas composed equally of oxygen and nitrous oxide, presented in bottle. The University Hospital of Nantes is currently conducting a general evaluation of the EMONO use in the hospital context. The department of odontology is part of this movement and wants to study the anxiolytic effect expected during dental care under MEOPA in children in the Dental Care Center. This analysis follows a previous study (MEOPAeDent) that subjectively took into account this anxiolysis.

Conditions

  • Dental Care for Children

Interventions

BEHAVIORAL

Evaluate the anxiolytic effect during dental care with MEOPA in children

Primary Purpose: The main objective of this study is to evaluate the anxiolytic effect of EMONO in children during dental care. Enrollment: 30

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Tony Prud'homme · Nantes University Hospital

Eligibility

Min Age
3 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-16
Primary Completion
2019-01-30
Completion
2019-01-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998774 on ClinicalTrials.gov